Stay updated on CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.

Latest updates to the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer “Revision” indicator is updated to v3.5.3 from v3.5.2, reflecting a software/version change rather than any modification to the underlying trial history details.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history. No substantive content changes to study data or user-facing information were introduced.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRecord History now includes a new revision entry v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check45 days agoChange DetectedThe history adds a new revision entry: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a new revision entry (v3.4.2) to the history. Removed the funding notice banner and the v3.4.1 entry.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a government funding status notice about potential delays and site operations. Updated the record version from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.